Watching ABVC Biopharma, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planABVC Biopharma, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
ABVC Biopharma postponed the distribution of BioKey (Cayman), Inc. ordinary shares originally scheduled for August 3, 2026, to allow time for finalizing administrative, regulatory, and tax-related requirements. The delay impacts shareholders who were expecting to receive 0.169464 BioKey shares per ABVC share held.
Key Takeaways
Distribution of BioKey shares postponed from August 3, 2026 to an unspecified future date
Record date for the distribution remains unchanged; shareholders will still receive 0.169464 BioKey shares per ABVC common share
2 more takeaways
Filing Overview
What This Means
ABVC Biopharma, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.